中国经济网北京10月10日讯 （记者 康博） 今年9月份，A股市场继续走高，尤其在科技股的带动下，创 业板大涨12%以上。在此背景下，1038只（各份额分开计算，下同）普通股票型基金中，9月份实现业 绩上涨的达815只，占比78%。另有1只持平，222只下跌。 从涨幅榜看，9月份5只涨幅超过30%的普通股基全被嘉实基金包揽，分别为嘉实新能源新材料股票A、 嘉实新能源新材料股票C、嘉实智能汽车股票、嘉实清洁能源股票发起式A、嘉实清洁能源股票发起式 C，涨幅分别为31.28%、31.22%、30.94%、30.27%、30.20%。 此外，宏利新能源股票A、宏利新能源股票C、易米低碳经济股票发起A、易米低碳经济股票发起C、华 夏能源革新股票A、华夏能源革新股票C、嘉实环保低碳股票、建信环保产业股票A、建信环保产业股 票C等多只重仓新能源个股的基金在9月份里也实现了25%以上的涨幅。 宏利新能源股票重仓的宁德时代、禾望电气（603063）、厦钨新能、美畅股份（300861）、金风科技 （002202）同样表现良好，其余的重仓股赛力斯（601127）、理想汽车也有不错的表现。易米低碳经济 股票则重仓了海博思创、星源材 ...

Core Insights - The article provides a ranking of open-end funds based on their net asset value growth as of August 20, 2025, highlighting the top and bottom performers in the market [2][4][6]. Fund Performance Summary - The top 10 funds with the highest net value growth include: 1. 嘉实绿色主题股票发起式A with a net value of 1.1888, up from 1.1232 [2] 2. 嘉实绿色主题股票发起式C with a net value of 1.1712, up from 1.1066 [2] 3. 宏利领先中小盘混合 with a net value of 0.9990, up from 0.9500 [2] 4. 中航远见领航混合发起C with a net value of 1.3618, down from 1.2951 [2] 5. 中航远见领航混合发起A with a net value of 1.3704, down from 1.3033 [2] 6. 国联安科创芯片设计ETF with a net value of 1.3214, up from 1.2581 [2] 7. 东方阿尔法优势产业混合A with a net value of 1.7251, up from 1.6440 [2] 8. 东方阿尔法优势产业混合C with a net value of 1.6814, up from 1.6024 [2] 9. 永赢半导体产业智选混合发起C with a net value of 1.4539, up from 1.3865 [2] 10. 永赢半导体产业智选混合发起A with a net value of 1.4715, up from 1.4033 [2] - The bottom 10 funds with the lowest net value growth include: 1. 申万赛信医药先锋股票C with a net value of 0.6109, down from 0.6369 [4] 2. 申万菱信医药先锋股票A with a net value of 0.6196, down from 0.6459 [4] 3. 华富健康文娱灵活配置混合C with a net value of 1.4777, down from 1.5389 [4] 4. 华富健康文娱灵活配置混合A with a net value of 1.4886, down from 1.5502 [4] 5. 红十创新医疗保健股票 with a net value of 1.5397, down from 1.5957 [4] 6. 东方阿尔法健康产业混合发起C with a net value of 1.1568, down from 1.1961 [4] 7. 东方阿尔法健康产业混合发起A with a net value of 1.1578, down from 1.1971 [4] 8. 恒生新药 with a net value of 2.0024, down from 2.0690 [4] 9. 金鹰责任投资混合A with a net value of 0.5689, down from 0.5876 [4] 10. 景顺长城医疗产业股票C with a net value of 1.6703, down from 1.7251 [4] Market Trends - The Shanghai Composite Index opened lower but rebounded, closing higher, while the ChiNext Index showed a W-shaped recovery with a slight increase [6]. - The total trading volume reached 2.44 trillion, with a market breadth of 3,676 gainers to 1,587 losers [6]. - Leading sectors included chemical fiber, semiconductors, and hotel catering, each with gains exceeding 3% [6].

Group 1 - The core viewpoint of the report indicates that the pharmaceutical and communication sectors performed well during the period, while the overall market saw declines in major indices [2][8][13] - The report highlights that the average return of actively managed equity funds decreased by 0.26%, while actively managed bond funds saw a slight increase of 0.08% [2][16] - The report notes that the long-term pure bond funds outperformed other bond categories, with an average return of 0.15% for the period [16][17] Group 2 - The report identifies that the pharmaceutical sector has shown strong performance, with several actively managed equity funds focused on this sector achieving high returns [14][15] - The report provides a detailed analysis of various fund categories, indicating that the average return for QDII funds varied significantly, with energy commodity QDII funds leading at 4.54% [18][20] - The report emphasizes that the average return for the equity funds in the Greater China region was notably high at 33.16% for the year [18][20]

Group 1 - The majority of stock and mixed funds achieved positive returns, with 89.57% reporting gains, and 52 funds exceeding a 5% return [1][2] - The Shanghai Composite Index rose by 0.43% to close at 3399.77 points, while the Shenzhen Component Index increased by 0.65%, and the ChiNext Index rose by 1.07% [1] - The top-performing sectors included pharmaceuticals, agriculture, and textiles, with respective increases of 2.30%, 1.72%, and 1.61% [1] Group 2 - The average net value growth rate for stock and mixed funds on June 9 was 0.68%, with 52 funds achieving over 5% growth [1][2] - The leading fund in terms of net value growth was Red Soil Innovation Healthcare Stock, with a growth rate of 7.36% [2] - Among the funds with over 5% growth, 9 belonged to Ping An Fund, while Great Wall Fund and Penghua Fund had 8 and 6 funds respectively [1][2] Group 3 - The funds with the highest net value declines included Gold Stock ETF, which fell by 1.11%, followed by Ping An and Guotai ETFs with declines of 1.10% and 1.09% respectively [2][3] - The data indicates a significant focus on healthcare-related funds, with multiple funds from Ping An Fund showing strong performance [1][2] - The report highlights the volatility in the gold sector, as evidenced by the performance of various gold-related ETFs [2][3]

Core Insights - The report indicates that the environmental protection sector performed well during the period, with QDII funds showing an average return that outperformed other fund types [1][7][17] - The Shanghai Composite Index experienced a slight decline of 0.03%, while the Shenzhen Component Index fell by 0.91% during the same period [1] - Among various fund types, QDII funds increased by 1.04%, contrasting with declines in actively managed stock funds, mixed funds, and bond funds [1] Fund Performance Summary - The environmental and pharmaceutical sectors were highlighted as strong performers in the recent 12 periods, with banks and beauty care also showing good performance [7] - Active stock funds focusing on the pharmaceutical sector yielded higher returns, with notable funds such as Hongtu Innovation Healthcare Stock Fund achieving a return of 9.67% [12][13] - In the bond market, convertible bond funds led with an average return of 3.90% year-to-date, while traditional bond funds showed mixed results [15][16] QDII Fund Insights - REITs QDII funds led the performance with a return of 2.41%, followed by equity funds focused on Europe and the US, which returned 1.70% [17][18] - The report notes that alternative asset classes, particularly gold-related QDII funds, have shown significant year-to-date growth of 25.91% despite a recent decline of 1.39% [17][18] - Representative QDII funds such as Morgan China Biopharmaceutical A and GF CSI Hong Kong Innovative Medicine ETF reported returns of 4.72% and 4.56%, respectively, during the period [19]